Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-Induced Cytotoxicity

    January 2022 in “ Journal of Cancer
    Celina Amaya, Elizabeth R. Smith, Xiang‐Xi Xu
    Image
    Studysummary This article reviews the potential for low intensity ultrasound as an antidote for the peripheral cytotoxic side effects of taxane drugs in chemotherapy, presenting no new clinical results. Our plain-language summary of this paper — not a Tressless recommendation.
    The document reviewed a laboratory discovery that low intensity ultrasound could serve as an antidote to the cytotoxic side effects of taxane drugs, such as paclitaxel, which are used in chemotherapy for major cancers. Taxanes, while effective, cause significant side effects like peripheral neuropathy and alopecia due to their impact on microtubules. The study found that brief exposure to low density ultrasound waves could eliminate paclitaxel cytotoxicity in cell cultures by breaking microtubule filaments, which were then disposed of in lysosomes. This suggests that ultrasound could potentially mitigate side effects like peripheral neuropathy and alopecia in cancer patients undergoing chemotherapy.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results